4th Quarter - Report

CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)

Firm
Client
Income
—
Expenses
$3,790,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Issues related to the competitive nature of the pharmacy benefit management industry and workforce issues, including reauthorization of the Workforce Innovation and Opportunity Act and national apprenticeship programs. S. 4295 - The Pharmacy Benefit Manager Transparency Act of 2022

LobbyistCovered position, as disclosed
ROBERT BUTORA —
KAITLYN LANE —
YUJIN LEE —
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
ROBERT TANNER WARBINTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4295 (117th)

Pharmacy PHA

Issues related to medication adherence, drug pricing transparency, and COVID testing and vaccination, including the Federal Retail Pharmacy Program. S. 1909, The Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R. 7213, The Equitable Community Access to Pharmacist Services Act P.L. 117-328, FY2023 Consolidated Appropriations Act

LobbyistCovered position, as disclosed
ROBERT BUTORA —
KAITLYN LANE —
YUJIN LEE —
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
MELISSA SCHULMAN —
ROBERT TANNER WARBINTON —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 7213 (117th), S. 1909 (117th)

Taxation/Internal Revenue Code TAX

Issues related to corporate tax rate and the Work Opportunity Tax Credit. H.R. 1304 - American Innovation and R&D Competitiveness Act of 2021 P.L. 117-328, FY2023 Consolidated Appropriations Act

LobbyistCovered position, as disclosed
JOY MCGLAUN —
SHANNON PENBERTHY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1304 (117th)

Medicare/Medicaid MMM

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to reimbursement for COVID-19 testing, vaccination, and treatment. HR 3173, Improving Seniors Timely Access to Care Act. P.L. 117-328, FY2023 Consolidated Appropriations Act

LobbyistCovered position, as disclosed
ROBERT BUTORA —
KAITLYN LANE —
YUJIN LEE —
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
MELISSA SCHULMAN —
ROBERT TANNER WARBINTON —

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3173 (117th)

Insurance INS

Issues related to employer, small group and individual insurance markets, including surprise billing and ACA subsidies.

LobbyistCovered position, as disclosed
KAITLYN LANE —
YUJIN LEE —
JOY MCGLAUN —
AMY ROSENBAUM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Issues related to organized retail crime and product safety. HR 5502, The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers Act H.R. 7900, National Defense Authorization Act for Fiscal Year 2023. S. 5406, The Combatting Organized Retail Crime Act of 2022 P.L. 117-328, FY2023 Consolidated Appropriations Act

LobbyistCovered position, as disclosed
ROBERT BUTORA —
JOY MCGLAUN —
SHANNON PENBERTHY —
ROBERT TANNER WARBINTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 5406 (117th), H.R. 7900 (117th), H.R. 5502 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.